gemcitabine has been researched along with ag-490 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan-On, W; Huyen, NT; Prachayasittikul, V | 1 |
1 other study(ies) available for gemcitabine and ag-490
Article | Year |
---|---|
Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
Topics: Anoikis; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Phosphorylation; Reference Values; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2016 |